In Loss For Boston Scientific, Panel Upholds Obviousness Findings
WASHINGTON, D.C. — A final written decision by the Patent Trial and Appeal Board that all claims of a patented Boston Scientific Neuromodulation Corp. patent are invalid as obvious was not...To view the full article, register now.
Already a subscriber? Click here to view full article